Furmaniak, J.
Sanders, J.
Sanders, P.
Miller-Gallacher, J.
Ryder, M. M.
Rees Smith, B.
Article History
Received: 18 November 2019
Accepted: 26 December 2019
First Online: 29 May 2020
Compliance with ethical standards
:
: J.F., J.S., P.S., J.M.G. and B.R.S. are employees of RSR Limited. RSR Limited is a developer of medical diagnostics including kits for measuring TSH receptor antibodies. J.F., J.S. and B.R.S. are Directors of AV7 Limited. AV7 Limited has no other competing interests to declare. K1-70 is currently in use as part of a Phase I, Single Ascending Intramuscular or Single Intravenous Dose, Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Subjects with Graves’ Disease (IRAS ID 199697, Eudract number 2014-003815-12).
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.